Partner Selection & Lessons Learned During Drug-Linker Development & Commercial Supply of Zynlonta®
Time: 9:45 am
day: Day One
Details:
• CMO selection criteria for drug linkers – a different yardstick than for ‘typical’ NCEs
• Upstream implications of downstream requirements – from raw materials to regulatory
• Case studies of process learnings in a joint operating model for SG3249 manufacture
